Inventaire - your friends and communities are your best library

Beta-agonist intrinsic efficacy: measurement and clinical significance

Author

Nicola A Hanania

Burton F Dickey

Published in: American Journal of Respiratory and Critical Care Medicine

Date of publication: May 1, 2002

Language: English

Bibliographic databases:

Cites articles 25

Date

Title

Authors

November 1, 1988

International trends in asthma mortality: 1970 to 1985.

, ,
May 1, 1989

Inhibition of beta-adrenergic receptor kinase prevents rapid homologous desensitization of beta 2-adrenergic receptors

,
December 1, 1990

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma
July 1, 1991

Comparative rates of desensitization of beta-adrenergic receptors by the beta-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase

, ,
September 1, 1995

Beta-adrenergic receptors and their regulation
September 1, 1997

beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists,β2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists
November 1, 1997

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency
May 1, 1997

Continuous isoproterenol inhalation therapy in children with severe asthmatic attack
November 1, 1997

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
April 1, 1998

Long-acting inhaled beta2-agonists in asthma therapy,Long-acting Inhaled β2-Agonists in Asthma Therapy
February 1, 1998

Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor,Salmeterol‐induced desensitization, internalization and phosphorylation of the human β2‐adrenoceptor
May 1, 1998

Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo
July 1, 1999

Partial agonists and G protein-coupled receptor desensitization
July 1999

Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients
April 1, 1999

A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group
May 1, 1999

Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
March 1, 2000

beta(2)-adrenergic receptor pharmacogenetics
September 1, 2000

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
July 1, 2000

The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma
September 1, 2000

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

, , ,
September 1, 2001

Long-acting inhaled beta(2)-agonist therapy in asthma
September 1, 2001

Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial
May 1, 2001

In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study
January 1, 2001

A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler
July 1, 2001

Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.

Article -

Welcome to inventaire

The library of your friends and communities

Learn more